10th Circ. Upholds FDA Win In Morphine Exemption Suit
A three-judge panel ruled that because Lannett and subsidiary Cody Laboratories Inc. can still petition the FDA to review its decision to consider their morphine sulfate product an unapproved new drug, they have not exhausted their administrative remedies, and a court can dismiss the suit.
Lannett and Cody...
To view the full article, register now.